Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Neumora Therapeutics, Inc. - Common Stock
(NQ:
NMRA
)
11.27
-0.52 (-4.41%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
282,215
Open
11.79
Bid (Size)
4.540 (2)
Ask (Size)
12.50 (1)
Prev. Close
11.79
Today's Range
11.24 - 12.14
52wk Range
8.330 - 21.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders
August 14, 2024
Roundtable discussion to take place on Thursday, September 12 at 8:00 a.m. ET
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
NMRA Stock Earnings: Neumora Therapeutics Meets EPS for Q2 2024
August 06, 2024
NMRA stock results show that Neumora Therapeutics met analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
-33.31%
-33.31%
1 Month
-5.29%
-5.29%
3 Month
+16.55%
+16.55%
6 Month
-42.97%
-42.97%
1 Year
-30.65%
-30.65%
More News
Read More
Neumora Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
August 06, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer’s Disease Agitation
June 20, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression
May 14, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
NMRA Stock Earnings: Neumora Therapeutics Meets EPS for Q1 2024
May 07, 2024
Via
InvestorPlace
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
May 07, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Neumora Therapeutics to Participate in Upcoming Conferences in May
May 06, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
S&P 500 Down Over 1%; US Retail Sales Increase 0.7% In March
April 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 15, 2024
Via
Benzinga
Crude Oil Down 1%; Charles Schwab Sales Top Estimates
April 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Neurology Focused-Neumora Therapeutics Shares Trading Lower On Monday?
April 15, 2024
Via
Benzinga
Exposures
Product Safety
Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug
April 15, 2024
Via
Investor's Business Daily
Why Is Mobile Global Esports (MGAM) Stock Down 18% Today?
April 15, 2024
Via
InvestorPlace
Why Is Neumora Therapeutics (NMRA) Stock Down 25% Today?
April 15, 2024
Via
InvestorPlace
Marinus Pharmaceuticals, Neumora Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
April 15, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 15, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 15, 2024
Via
InvestorPlace
Neumora Therapeutics Announces Clinical Hold of Phase 1 NMRA-266 Study
April 15, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 13, 2024
Via
Benzinga
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 13, 2024
Via
Benzinga
Dollar Tree Reports Weak Earnings, Joins Tesla, Arcos Dorados And Other Big Stocks Moving Lower On Wednesday
March 13, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Neumora Therapeutics to Participate at Stifel 2024 Virtual CNS Days
March 13, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
NMRA Stock Earnings: Neumora Therapeutics Misses EPS for Q4 2023
March 07, 2024
Via
InvestorPlace
Neumora Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
March 07, 2024
From
Neumora Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.